Resources
Selected peer-reviewed publications co-authored by The Knowledge House Partners
- Social media mining in drug development-Fundamentals and use cases. Drug Discovery Today. (2021)
- Utilizing machine learning to improve clinical trial design for acute respiratory distress syndrome. Nature Digital Medicine. (2021)
- Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042). J Med Chem. (2021)
- Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure. Eur J Heart Fail. (2021)
- Danger in the Valley of Death: how the transition from preclinical research to clinical trials can impact valuations. Drug Discovery Today. (2020)
- Digital Competencies and Attitudes Toward Digital Adherence Solutions Among Elderly Patients Treated With Novel Anticoagulants: Qualitative Study. J Med Internet Res. (2020)
- Transformation of the German Health Care System – Perception of the Progressing Digitization among Experts and the Public: A Mixed Method Study. JMIR Public Health Surveill. J Med Internet Res. (2019)
- Vascular protection and decongestion without RAAS stimulation mediated by a novel dual acting vasopressin V1a/V2 receptor antagonist. J Cardiovasc Pharmacol. (2019)
- Future Unmet Medical Need as guiding principle for Pharmaceutical R&D. Drug Discovery Today. (2019)
- A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction. Eur J Appl Physiol. (2019)
- How soon will digital endpoints become a cornerstone for future drug development? Drug Discovery Today. (2019)
- Digital transformation of the health care sector: What kind of disruption is underway? J Med Internet Res. (2018)
- Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease. Am J Respir Cell Mol Biol. (2018)
- New digital adherence devices could prevent millions of strokes from atrial fibrillation by the end of the next century. Med Hypotheses. (2017)
- Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure. J Med Chem. (2017)